Dose Escalation Trial of Traditional Chinese Medicine for Irritable Bowel Syndrome (TCM- IBS)
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a 20- herb formulation, as a well
characterised extract, is efficacious in treating irritable bowel syndrome (IBS) and also to
identify efficacious and safe dosage of the formulation in treating IBS.
Phase:
Phase 2
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore
Collaborators:
Chinese University of Hong Kong National Center for Complementary and Integrative Health (NCCIH)